Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02299596
Other study ID # Physsurg C - the RCT
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date January 2015
Est. completion date December 31, 2025

Study information

Verified date November 2023
Source Sahlgrenska University Hospital, Sweden
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will compare the outcome after surgery between a group of patients that receives instructions for prehabilitation training and one group that received standard treatment.


Description:

The aim of this study is to investigate whether a training program with intensified physical activity prior to and after a surgical procedure reduces the surgical-related postoperative recovery time, hospital stay, sick leave and complication rate. A secondary aim is to investigate the effect of a training program with pre- and post- operative PA on the rate of resumption of QoL and normal physical function.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 761
Est. completion date December 31, 2025
Est. primary completion date May 31, 2020
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Diagnosed colorectal cancer and a planned surgical procedure Exclusion Criteria: - HIPEC surgery, not able to give informed consent or understand the intervention

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Physical activity
The intervention will take place both pre- and postoperatively. During the hospital stay both groups will be treated in the same manner.

Locations

Country Name City State
Sweden Sahlgrenska University Hospital/Östra Göteborg
Sweden Dept. of Surgery, Skaraborgs Sjukhus Skövde

Sponsors (1)

Lead Sponsor Collaborator
Sahlgrenska University Hospital, Sweden

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recovery measured as physical recovery measured in questionnaire 4-6 weeks
Secondary Psychological recovery measured in a questionnaire, patient reported Recovery 4-6 weeks and 1 year post-operatively
Secondary Recovery measured as time back to work Recovery 1 year
Secondary Complications according to Clavien-Dindo Postoperative complications within 90 days
Secondary QoL measured using SF-36 QoL according to SF-36 4-6 weeks and 1 year
Secondary QoL measured using EQ-5D QoL according to EQ-5D 4-6 weeks and 1 year
Secondary QoL measured using a specifically developed instrument for this study Health related QoL 4-6 weeks and 1 year
Secondary Mortality Long term mortality 3 and 5 years
Secondary Re-admissions Hospital re-admissions 1 year
Secondary Reoperations Reoperations 1 year
Secondary Total time of hospital stay Length of stay 1 year
Secondary IGF-1 and IGFBP-3 Lab values 4 weeks postopeartively
Secondary Postoperative pain measured with Brief Pain Inventory-Short form Pain measured by BPI-S 4 weeks
Secondary Postoperative pain measured with Brief Pain Inventory-Short form Pain measured by BPI-S 12 months
Secondary Health economic analysis Health economic analysis modified according to results of primary outcome 4 weeks
Secondary Health economic analysis Health economic analysis modified according to results of primary outcome 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT05400122 - Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer Phase 1
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Completed NCT00098787 - Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05425940 - Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer Phase 3
Suspended NCT04595604 - Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery. N/A
Completed NCT03414125 - Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening N/A
Completed NCT02963831 - A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies Phase 1/Phase 2
Recruiting NCT05489211 - Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) Phase 2
Terminated NCT01847599 - Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT03874026 - Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients Phase 2
Active, not recruiting NCT03170960 - Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Phase 1/Phase 2
Completed NCT03181334 - The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation N/A
Completed NCT03167125 - Participatory Research to Advance Colon Cancer Prevention N/A
Recruiting NCT04258137 - Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study N/A
Recruiting NCT05568420 - A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
Recruiting NCT02972541 - Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer N/A
Completed NCT02876224 - Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors Phase 1
Completed NCT01943500 - Collection of Blood Specimens for Circulating Tumor Cell Analysis N/A